Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the C1 domain of factor VIII

Details for Australian Patent Application No. 2007217218 (hide)

Owner LFB Biotechnologies

Inventors Saint-Remy, Jean-Marie; Behrens, Christian; Gilles, Jean-Guy; Jacquemin, Marc G.

Agent Spruson & Ferguson

Pub. Number AU-A-2007217218

PCT Pub. Number WO2007/096536

Priority 0601633 24.02.06 FR

Filing date 26 February 2007

Wipo publication date 30 August 2007

International Classifications

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/096536 Priority application(s): WO2007/096536

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217252-Herbicidal isoxazoline compounds

2007217215-Infectivity assay